Literature DB >> 26559900

Safety evaluation of AMP deaminase from Aspergillus oryzae.

Nobuo Okado1, Mai Sugi2, Maya Ueda2, Fukutaro Mizuhashi2, Barry S Lynch3, Trung D Vo3, Ashley S Roberts3.   

Abstract

Adenosine-5'-monophosphate (AMP) deaminase is an enzyme used to increase concentrations of 5'-inosine monophosphate in certain foods and beverages for flavoring purposes. One commercial source of this enzyme is Aspergillus oryzae, a filamentous fungus with a history of safe use in Asia as a fermentation organism used in the production of miso sauce and sake liquors. Noting the use of the enzyme in food intended for human consumption and potential presence at trace levels in finished goods, a series of safety studies including an in vitro Ames test and chromosome aberration assay with Chinese hamster lung fibroblasts were conducted along with a 90-day oral toxicity study in rats. AMP deaminase showed no evidence of genotoxicity in the in vitro tests. Following gavage administration of Sprague-Dawley rats at dosages of 19.8, 198.4, or 1984 mg total organic solids (TOS)/kg body weight (bw)/day for 90 days, no adverse effects on body weight gain, food consumption, hematology, clinical chemistry, urinalysis, ophthalmological and histopathological examinations were observed. The no-observed-adverse-effect level was considered to be 1984 mg TOS/kg bw/day, the highest dose tested. Results of the genotoxicity studies and subchronic rat study support the safe use of AMP deaminase produced from A. oryzae in food production.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenosine-5’-monophosphate deaminase; Food; Genotoxicity; Rat; Safety; Subchronic toxicity

Mesh:

Substances:

Year:  2015        PMID: 26559900     DOI: 10.1016/j.fct.2015.11.001

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  2 in total

1.  Crohn's Disease-Like Ileitis and the Inhibitory Effect of Sucralose on Streptococci.

Authors:  Alexander Rodriguez-Palacios; Fabio Cominelli
Journal:  Inflamm Bowel Dis       Date:  2019-03-14       Impact factor: 5.325

2.  Safety assessment of glutaminase from Aspergillus niger.

Authors:  Trung Duc Vo; Christina Sulaiman; Shahrzad Tafazoli; Barry Lynch; Ashley Roberts; Go Chikamatsu
Journal:  Food Sci Nutr       Date:  2020-02-18       Impact factor: 2.863

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.